Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam to prevent emergence agitation after adult nasal endoscopic surgery
ChiCTR2300075300Phase 4Completed
- Sponsor
- Lishui People's Hospital
- Start
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in Emergence agitation (EA) comparing Remimazolam arm with Control arm (normal saline placebo) (2 arms). Primary endpoint: Emergence agitation. Started Sep 2023; status: completed.
02
Drugs
remimazolam
03
Conditions
Emergence agitation (EA)
Beyond the preview
Go deeper on ChiCTR2300075300.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300075300.